Prosecution Insights
Last updated: April 19, 2026

Examiner: LANCASTER, LINDSAY REGAN

Tech Center 3700 • Art Units: 3794

This examiner grants 56% of resolved cases

Performance Statistics

55.8%
Allow Rate
-14.2% vs TC avg
142
Total Applications
+26.2%
Interview Lift
1418
Avg Prosecution Days
Based on 95 resolved cases, 2023–2026

Rejection Statute Breakdown

3.2%
§101 Eligibility
19.5%
§102 Novelty
67.4%
§103 Obviousness
5.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18565650 METHODS AND DEVICES FOR ELECTROPORATION FOR TREATMENT OF VENTRICULAR FIBRILLATION Non-Final OA Mayo Foundation for Medical Education and Research
17150188 Vapor Ablation System with Simplified Control Over Vapor Delivery Non-Final OA Aqua Medical, Inc.
17874583 ELECTRICAL FIELD VISUALIZATION FOR ELECTROPORATION CATHETER WITH MULTIPLE STATES Non-Final OA Boston Scientific Scimed, Inc
17545109 MEDICAL DEVICES AND RELATED METHODS Final Rejection Boston Scientific Scimed, Inc.
17129043 CUSTOMIZED WAVEFORM AND CONTROL FOR PULSED ELECTRIC FIELD ABLATION SYSTEMS Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
16686591 SHEATH DETECTION USING LOCAL IMPEDANCE INFORMATION Final Rejection Boston Scientific Scimed Inc.
17303591 MEDICAL TREATMENT SYSTEM Non-Final OA Covidien LP
17704491 MEDICAL DEVICE Final Rejection TERUMO KABUSHIKI KAISHA
18365502 TWO-MODE MORCELLATION DEVICE Non-Final OA Gyrus ACMI, Inc. D/B/A Olympus Surgical Technologies America
17653486 DISTAL WIRE ROUTING FOR STRAIGHT JAW FORCEPS Non-Final OA GYRUS ACMI, INC,D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
17461270 METHOD AND SYSTEM FOR PREDICTING CURRENT PATHS AND EVALUATING ELECTRICAL BURN RISKS OF A MONOPOLAR ELECTROSURGERY TOOL Non-Final OA Verb Surgical Inc.
18383726 GRAPHICALLY ENCODED ABLATION TAGS ACCORDING TO REGIONS OF ANATOMY Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.
18482815 CATHETER INSERTION TOOL Non-Final OA Biosense Webster (Israel) Ltd.
17566336 Basket Catheter Having Ablation Electrodes and Temperature Sensors Non-Final OA Biosense Webster (Israel) Ltd.
17555220 Irreversible Electroporation Return Electrode and System Non-Final OA Biosense Webster (Israel) Ltd.
17347986 CATHETER FOR HIGH-POWER FOCAL ABLATION Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.
17124679 GUI FOR HIGHLIGHTING SIGNALS PRIOR, DURING, AND POST ABLATION USING MULTI-ELECTRODE CATHETERS Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
17678102 PULSED ELECTRIC FIELD (PEF) INDEX Non-Final OA Medtronic, Inc.
17247198 ELECTROPORATION SYSTEM AND METHOD Final Rejection St. Jude Medical, Cardiology Division, Inc.
18406612 SYSTEMS AND METHODS FOR ABLATION OF A THYROID NODULE Non-Final OA Medtronic Xomed LLC
17222480 DEVICES AND METHODS FOR THE TREATMENT OF TISSUE Non-Final OA Fractyl Health, Inc.
17719687 ELECTRODE INSTRUMENT, SURGICAL HANDHELD DEVICE, AND THEIR PRODUCTION METHODS Non-Final OA OLYMPUS WINTER & IBE GMBH
17677044 ELECTROSURGICAL HANDHELD DEVICE, AND CONTACT BODY FOR AN ELECTROSURGICAL HANDHELD DEVICE Non-Final OA Olympus Winter & Ibe GmbH
18481220 DEVICES, METHODS AND SYSTEMS FOR RENAL DENERVATION Non-Final OA Otsuka Medical Devices Co., Ltd.
18440870 METHOD AND SYSTEMS FOR REDUCING TREATMENT VARIABILITY AND INCREASING TREATMENT EFFICACY AND DURABILITY Non-Final OA Nuvaira, Inc.
18480201 SYSTEMS AND METHODS FOR IMPROVED DELIVERY OF EXPANDABLE CATHETER ASSEMBLIES INTO BODY LUMENS Final Rejection Nuvaira, Inc.
17921717 ELECTRODE APPARATUS Final Rejection DEEPQURE INC.
18398468 Anterior Mitral Leaflet Laceration Device and Methods of Making and Using Same Final Rejection Tendyne Holdings, Inc.
18285764 EXCISION CATHETER SYSTEM FOR AN AORTIC VALVE Final Rejection Excision Medical, Inc.
18553996 RENAL DENERVATION CATHETER Non-Final OA NU EYNE CO.,LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month